Ask a group of friends how they handle money, and you’ll get wildly different answers. One might day-trade on a whim, another might obsess over retirement accounts, and a third might freeze up at the thought of any financial decision at all. What accounts for these differences? Part of the answer, according to a growing body of research, lies in a single brain chemical: dopamine.
A review published in Brain Sciences pulls together decades of scattered findings on how dopamine influences the way people weigh risk, delay gratification, judge fairness, and learn from feedback when money is on the line. The authors, Luca Aquili of Ritsumeikan Asia Pacific University and Lee Wei Lim of Xi’an Jiaotong-Liverpool University, argue that dopamine does not simply make people reward-hungry. Instead, it shapes economic behavior through several distinct biological routes.
The knowledge gap
Dopamine is best known as the brain’s reward-prediction signal, a chemical messenger that helps animals learn what actions pay off. It is also implicated in addiction, Parkinson’s disease, and schizophrenia. Over the past two decades, researchers have increasingly examined its role in economic behavior, but the findings have been scattered across different methods and populations.
Aquili and Lim wanted to organize what is known about dopamine and financial decision-making in healthy adults. They focused on five distinct angles: drugs that alter dopamine levels, specific dopamine receptor types (labeled D1 through D4), brain circuits visible through imaging, genetic variations that tweak dopamine signaling, and stable personality traits linked to dopamine function.
A quick primer on dopamine
Dopamine is released by neurons in deep brain regions and travels to areas like the striatum (involved in habit and reward) and the prefrontal cortex (involved in planning and self-control). It binds to several receptor subtypes, each doing slightly different jobs. Genes such as DRD2, DRD4, COMT, and DAT1 influence how much dopamine is produced, how long it sticks around, and how strongly receptors respond to it.
How the review was conducted
The authors gathered studies using three main approaches. The first involved pharmacology, where participants were given drugs that raise or lower dopamine activity, such as L-DOPA (a dopamine precursor) or haloperidol (a receptor blocker). The second used brain imaging techniques like fMRI and PET scans to watch dopamine systems in action. The third examined genetic variations linked to differences in dopamine signaling.
Participants in these studies completed economic tasks familiar to behavioral economists. These included the Ultimatum Game (where one person offers to split money and the other can accept or reject), delay discounting tasks (choosing between smaller-sooner and larger-later rewards), investment simulations, and foraging tasks that mimic real-world trade-offs.
What the evidence revealed
Several patterns emerged across the studies.
When researchers boosted dopamine levels, behavior shifted in ways that depended heavily on context. Giving participants L-DOPA made them more selfish in a bargaining game, but only when there was no risk of being punished for unfair behavior. In another study, the same drug made people cling to optimistic beliefs, updating their expectations when they received good news but ignoring bad news. A different drug called tolcapone, which raises dopamine in the prefrontal cortex, made people more sensitive to unfair offers rather than simply more generous.
Studies zeroing in on the D2 receptor found it plays an outsized role. People with more D2 receptors available in certain brain regions were better at switching strategies when market-like conditions changed, while those with fewer tended to stick with losing choices. Blocking D2 receptors with haloperidol reduced impulsive choices in one study, pushing people toward patience.
Brain imaging studies linked activity in the nucleus accumbens, a dopamine-rich area, to financial risk-taking. In one notable finding, participants who viewed erotic images before making investment choices showed heightened activity in this region and went on to pick riskier options. A neighboring region called the insula, associated with negative feelings, predicted the opposite pattern: more caution.
Genetic studies added another layer. People carrying a particular variant of the DRD4 gene (the 7-repeat allele) tended to discount future rewards more steeply, though findings on risk-taking were inconsistent. Variations in the COMT gene, which controls how quickly dopamine is broken down in the prefrontal cortex, predicted differences in how people learned from feedback during strategic economic games.
Finally, a handful of studies examined long-term traits. Senior investors showed greater gray matter volume in dopamine-rich brain regions compared with junior ones, and Wall Street traders with genetic profiles linked to moderate dopamine levels tended to have longer careers.
Takeaways and caveats
For businesspeople, investors, and managers, the review suggests that financial decision-making is not purely a matter of logic or willpower. Individual biology shapes how people respond to uncertainty, fairness, and feedback. Understanding that colleagues or clients may have genuinely different baseline responses to risk could inform team composition, client advising, and even the design of decision-support tools.
A few caveats matter. Most of the studies involved small samples of healthy adults in controlled laboratory tasks, not real financial markets with real consequences. Genetic findings have sometimes failed to replicate. And while dopamine is a major player, it interacts with other neurotransmitters like norepinephrine and serotonin that also shape economic choices.
The authors note that dopamine’s effects are not uniformly helpful. More dopamine can sharpen goal-directed behavior when outcomes are clear, but can distort judgment when feedback is ambiguous. In short, there is no “optimal” dopamine level for making money. The chemistry that helps one person spot opportunity may lead another to double down on a losing bet.
